Advertisement
The 21st Century Cures Act ignores value

The 21st Century Cures Act ignores value

By Merrill Goozner  |  May 23, 2015

As Congress barrels toward passage of the 21st Century Cures Act, it has failed to ask a crucial question: Will it help or harm the nation's drive to derive greater value from its healthcare dollars?

Accountable care's rocky road

Accountable care's rocky road

By Merrill Goozner  |  May 09, 2015

Medicare's 32 Pioneer accountable care organizations posted mixed results after two years, revealing once again that making money from care coordination is proving a heavy lift for most provider organizations.

Beware a 21st Century Quackery Act

Beware a 21st Century Quackery Act

By Merrill Goozner  |  May 02, 2015

Proposed legislation “modernizing” the Food and Drug Administration's approach to approving breakthrough drugs and devices would undermine the agency's ability to protect the American public from unproven and possibly unsafe new products.

Saving young brains

Saving young brains

By Merrill Goozner  |  April 25, 2015

Every year, more than a million children under age 3 undergo operations in the nation's hospitals using anesthetics that the Food and Drug Administration and many clinical scientists fear may be damaging their developing brains.

Interoperability—A dream deferred

Interoperability—A dream deferred

By Merrill Goozner  |  April 17, 2015

Most Americans who receive care at more than one location still don't have their “complete” record in front of their attending physician. Heck, most providers can't or won't even send their patients' electronic records across town, much less to a neighboring state or across the country.

An unwarranted role for physician specialty boards

An unwarranted role for physician specialty boards

By Merrill Goozner  |  April 11, 2015

The Medicare SGR replacement bill that most likely will pass Congress this week makes sweeping changes to Medicare's programs for rewarding or penalizing physicians on quality, cost and their adoption of EHRs. It also gives medical specialty boards an unwarranted role in how those rewards or...

Their own private Idaho

Their own private Idaho

By Merrill Goozner  |  April 04, 2015

Idaho, famous for its pine forests, crystalline lakes and baking potatoes, has a scant 1.6 million people spread over its 82,643 square miles. Yet it has seized center stage in setting national healthcare economic policy.

The SGR fix helps the value-based care evolution

The SGR fix helps the value-based care evolution

By Merrill Goozner  |  March 28, 2015

The incentives in the permanent “doc-fix” legislation, which now has overwhelming bipartisan support from both houses of Congress and the president, will not, by themselves, drive physicians toward value-based compensation schemes.

The spending slowdown is real

The spending slowdown is real

By Merrill Goozner  |  March 14, 2015

Over the past two years, conventional wisdom presumed without offering much in the way of evidence that the lingering recession and the rise of high-deductible and narrow network plans explained the slowdown in healthcare spending, now in its fifth year.

The high price of precision medicine

The high price of precision medicine

By Merrill Goozner  |  March 07, 2015

Financial markets have sent another signal that the coming era of precision or personalized medicine could wind up making cancer care unaffordable for millions of people.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.